What is Onda?
ONDA Corporation operates at the intersection of advanced diagnostic imaging and therapeutic instrumentation. As a specialized manufacturer, the firm provides critical hydrophone technology, preamplifiers, and sophisticated calibration systems that serve as the backbone for medical and industrial ultrasound applications. With an ISO/IEC 17025-2017 accreditation, ONDA maintains a rigorous standard of precision, catering to sectors ranging from physiotherapy to complex therapeutic device development. Their proprietary innovations, such as the CMS-0300 cavitation monitoring sensor, underscore their commitment to technical excellence and market-leading reliability in acoustic measurement.
How much funding has Onda raised?
Onda has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Onda
PPP
Public-Private Partnership
What's next for Onda?
With the successful acquisition of this late-stage capital, ONDA is poised to transition into a phase of aggressive market expansion and product diversification. The strategic roadmap likely involves scaling the production of their core instrumentation lines while deepening their footprint in the therapeutic ultrasound market. By leveraging this financial backing, the company can further invest in R&D to maintain its competitive edge, potentially exploring new industrial applications for its sensor technology. As the demand for high-fidelity diagnostic tools continues to rise, ONDA's focus will remain on operational efficiency and the continued refinement of its calibration services to meet evolving global regulatory standards.
See full Onda company page
